No Detail Found!

Procalcitonin/Albumin Ratio as a Novel Biomarker for Predicting Mortality in COVID-19

Author(s)
Hasan Ergenç Department of Internal Medicine, Ayancık State Hospital,Sinop,Turkey
Zeynep Ergenç Department of Internal Medicine, Ayancık State Hospital,Sinop,Turkey
Cemal Koray Öztürk Department of Anesthesiology, Yenikent State Hospital,Sakarya,Turkey
Hasan Tahsin Gozdas Department of Infectious Diseases and Clinical Microbiology, Abant İzzet Baysal University, Faculty of Medicine,Bolu,Turkey
Özlem Karaca Ocak Department of General Surgery, Medicana International Hospital,Samsun,Turkey
Özgür İnce Department of Pulmonology, Medicana International Hospital,Samsun,Turkey
Abstract
Background: Coronavirus disease 2019 (COVID-19) first appeared in China in December 2019, and has become a global pandemic. Because the clinical progression of the disease is highly variable, better prediction of prognosis and mortality is important. In the present study, we investigated the role of procalcitonin/albumin ratio (PAR) as a new biomarker in predicting mortality in patients with COVID-19 infection. Methods: In this study, patients with COVID-19 diagnosis were enrolled from Sakarya Yenikent State Hospital and Ayancik State Hospital between 09.11.2020 and 04.05.2021. The demographic characteristics, biochemical and hematological parameters such as age, gender, length of hospital stay, and comorbidities of the patients were collected retrospectively from medical records. Conclusion: We report that PAR, a simple, cheap, and easily accessible biomarker, can be used to predict the prognosis in patients with COVID-19 infection.
Publication Details
Page(s) 3-7
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 11, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Procalcitonin/albumin ratio, Covid-19, prognosis, COVID-19, Mortality
References
Bernard Stoecklin S,Rolland P,Silue Y,Mailles A,Campese C,Simondon A,Mechain M,Meurice L,Nguyen M,Bassi C,Yamani E,Behillil S,Ismael S,Nguyen D,Malvy D,Lescure FX,Georges S,Lazarus C,Tabaï A,Stempfelet M,Enouf V,Coignard B,LevyBruhl D,Surveill Euro .2020 .First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures. , 25(6) : 2000094.
Abrishami A,Khalili N,Dalili N,Khaleghnejad Tabari R,Farjad R,Samavat S .2020 .Clinical and radiologic characteristics of COVID-19 in patients with CKD. Iran J Kidney Dis, 14(4) : 267-77.
Carey IM,Critchley JA,DeWilde S,Harris T,Hosking FJ,Cook DG .2018 .Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care, 41(3) : 513-21.
Richardson S,Hirsch JS,Narasimhan M,Crawford JM,McGinn T,Davidson KW .2020 .Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, 323(20) : 2052.
Gallo Marin B,Aghagoli G,Lavine K,Yang L,Siff EJ,Chiang SS,Salazar-Mather TP,Dumenco L,Savaria MC,Aung SN,Flanigan T,Michelow IC . .Predictors of COVID-19 severity: A literature review. Rev Med Virol., : .
.2020 .Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect, 9(1) : 1123-1130.
Xu P,Sriramula S,Lazartigues E. .2011 .ACE2/ANG-(1- 7)/Mas pathway in the brain: the axis of good. Am J Physiol Regul Integr Comp Physiol, 300(4) : R804-17.
Cheng MP,Papenburg J,Desjardins M,Kanjilal S,Quach C,Libman M .2020 .Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2. , 172(11) : 726-34.
García de Guadiana‐Romualdo L,Morell‐García D,Morales‐Indiano C,Bauça JM,Alcaide Martín MJ,Esparza Del Valle C .2021 .Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID‐19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID‐Spain study). Scand J Clin Lab Invest, 81(3) : 187-93.
Pourbagheri‐Sigaroodi A,Bashash D,Fateh F,Abolghasemi H .2020 .Laboratory findings in COVID‐19 diagnosis and prognosis. Clin Chim Acta, 510 : 475-82.
Ahmed S,Siddiqui I,Jafri L,Hashmi M,Khan AH,Ghani F .2018 .Prospective evaluation of serum procalcitonin in critically ill patients with suspected sepsis - experience from a tertiary care hospital in Pakistan. Ann Med Surg (Lond), 35 : 180-4.
Ke C,Wang Y,Zeng X,Yang C,Z. C .2020 .Novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases. Clin Biochem, 81 : 9-12.
Carpenter RC,Mudd AP,West CP,Wilber E,Wilber ST .2020 .Diagnosing COVID-19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases. Acad Emerg Med, 27(8) : 653-70.
Nazerian P,Gagliano M,Fanelli A,Grifoni S .2021 .Prognostic Role of Procalcitonin in Patients with Fever and Respiratory Complains During the COVID-. Pandemic. SN Compr Clin Med, 3(5) : 1074-1075.
Ahmed S,Jafri L,Hoodbhoy Z,Siddiqui I .2021 .Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review. Indian J Crit Care Med, 25(1) : 77-84.
Rothschild MA,Oratz M,Schreiber SS .1988 .Serum albumin. Hepatology, 8(2) : 385-401.
Akirov A,Masri-Iraqi H,Atamna A,Shimon I .2017 .Low albumin levels are associated with mortality risk in hospitalized patients. Am J Med, 130(12) : e11-1465.
Soeters PB,Wolfe RR,Shenkin A,Significance. JPEN J Parenter Enteral Nutr Clinical .2019 .. , 43(2) : 181-193.
Huang J,Cheng A,Kumar R,Fang Y,Chen G,Zhu Y .2020 .Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol, 92(10) : 2152-8.
Shao S,Zhao Z,Wang F .2020 .Risk factors associated with disease aggravation among 126 hospitalized patients with COVID-19 in different places in China: A retrospective observational study. Medicine (Baltimore), 99(45) : e22971.
0

Citations

0

Downloads

11

Views